Advances in Pharmacology and Pharmacy · 2014 · 21 citations · 21 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDissolution TestingPharmaceutical FormulationAntifungal AgentsComparative Dissolution TestingDrug DissolutionDrug SolubilitySolubility EnhancementSolubility OptimizationLow SolubilityMolecular Inclusion ComplexesPh-dependent Drug SolubilitySalt DissolutionSolubilitySolubility - Dissolution RelationshipSolubility DeterminationSolute Solubility
Itraconazole is a potent triazole antifungal drug which has low solubility at physiological pH conditions. Itraconazole is weakly basic (pKa =3.7) and highly hydrophobic drug. It is categorized as a BCS class II drug. The main objective of the present investigation was to improve the solubility of itraconazole, by preparation of salt forms itraconazole hydrochloride, mesylate and besylate by using addition reaction with hydrochloric acid, methane sulphonic acid and benzene sulphonic acid. Further inclusion complexes of itraconazole were prepared with Captisol (sulfobutyl ether<sub>7</sub> β-cyclodextrin) by using physical mixing, kneading and co-evaporation techniques. The preparations were characterized by using X-ray diffraction, Fourier Transformed Infrared spectroscopy and Nuclear Magnetic Resonance spectroscopy. The solubility of prepared salt was found multifold than the solubility of itraconazole. The dissolution studies exhibited higher percentage drug dissolution from itraconazole complexes than that of the pure drug which can be attributed to the increase in drug solubility provoked by the complexation technique.
21
Handbook of Pharmaceutical Excipients
Flynn W. Warren · American Journal of Health-System Pharmacy · 1987 · 3.3K citations
T. Higuchi, A Connors · 1965 · 2.5K citations
Mathematical comparison of dissolution profiles
J. W. Moore, Henry H. Flanner · Pharmaceutical technology · 1996 · 1.1K citations
The concept of dissolution efficiency
Kamran Khan · Journal of Pharmacy and Pharmacology · 1975 · 977 citations